You are here

Article Text

Article menu
Download PDFPDF
Short report
Neonatal paroxetine withdrawal syndrome
  1. J A Stiskala,
  2. N Kulinb,
  3. G Korenb,
  4. T Hob,
  5. S Itob
  1. aDivision of Neonatology, Morristown Memorial Hospital, Morristown, New Jersey, USA, bDivision of Clinical Pharmacology and Toxicology, Motherisk Program, Department of Pediatrics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8
  1. Dr Itoito{at}sickkids.on.ca

Abstract

Four term neonates presented with symptoms such as jitteriness and necrotising enterocolitis after paroxetine exposure in utero.

Key messages

Key messages

  • Paroxetine withdrawal syndrome was suspected in four neonates exposed to the drug in utero at maternal doses ranging from 20 to 120 mg/day

  • The symptoms and abnormalities included, but were not limited to, jitteriness, vomiting, irritability, hypoglycaemia, and necrotising enterocolitis

  • Close observation is warranted for neonates exposed to paroxetine in utero

  • neonates
  • paroxetine
  • withdrawal
  • serotonin reuptake inhibitors
  • necrotising enterocolitis

https://doi.org/10.1136/fn.84.2.F134

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Linked Articles